A comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions.
A comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions.
复制标题
丁丙诺啡诱导策略的比较:以患者为中心的家庭归纳与护理标准的基于办公室的归纳。
DOI:
10.1016/j.jsat.2010.12.002
复制
发表时间:
2011-06
影响因子:
3.9
通讯作者:
Sohler NL
中科院分区:
文献类型:
--
作者:
Cunningham CO;Giovanniello A;Li X;Kunins HV;Roose RJ;Sohler NL
Although novel buprenorphine induction strategies are emerging, they have been inadequately studied. To examine our newly developed patient-centered home-based inductions, we conducted a subgroup analysis of 79 opioid-dependent individuals who had buprenorphine inductions at an urban community health center. Participants chose their induction strategy; standard-of-care office-based inductions were physician-driven, with multiple assessments, and observed, and patient-centered home-based inductions emphasized patient self-management and included a “kit” for induction at home. We conducted interviews and extracted medical records. Using mixed non-linear models, we examined associations between induction strategy and opioid use and any drug use. Compared to those with standard-of-care office-based inductions, participants with patient-centered home-based inductions had no significant differences in opioid use (AOR=0.63, 95%CI=0.13–2.97), but greater reductions in any drug use (AOR=0.05, 95%CI=0.01–0.37). Taking into account the limitations of our observational cohort study design, we conclude that participants with patient-centered home-based inductions had similar reductions in opioid use and greater reductions in any drug use than those with standard-of-care office-based inductions. It is essential that new induction strategies be based on existing models or theories and well-studied.